NB‐UVB and azathioprine combined therapy for patients with non‐segmental vitiligo
Experimental Dermatology · 2024
DOI: 10.1111/exd.15039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Dermatology, 2024. Verfasst von O Yu Olisova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation. Hauptthemen laut MEDLINE: Vitiligo, Ultraviolet Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
- Institute for Regenerative Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
ORCID-Profile: L N Kayumova
Zitieren
APA
Olisova, O. Y., Vovdenko, K. A., Kayumova, L. N., Koteneva, P. I., & Lomonosov, K. M. (2024). NB‐UVB and azathioprine combined therapy for patients with non‐segmental vitiligo. Experimental Dermatology. https://doi.org/10.1111/exd.15039
Vancouver
Olisova OY, Vovdenko KA, Kayumova LN, Koteneva PI, Lomonosov KM. NB‐UVB and azathioprine combined therapy for patients with non‐segmental vitiligo. Experimental Dermatology. 2024. doi:10.1111/exd.15039
BibTeX
@article{Olisova2024,
author = {Olisova, O Yu and Vovdenko, K A and Kayumova, L N and Koteneva, P I and Lomonosov, K M},
title = {NB‐UVB and azathioprine combined therapy for patients with non‐segmental vitiligo},
journal = {Experimental Dermatology},
year = {2024},
doi = {10.1111/exd.15039}
}
EUVIMED